nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Fludrocortisone—Eplerenone—coronary artery disease	0.329	1	CrCrCtD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Captopril—coronary artery disease	0.00363	0.383	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Perindopril—coronary artery disease	0.00196	0.207	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Trandolapril—coronary artery disease	0.00153	0.161	CbGdCrCtD
Fluocinolone Acetonide—Fludrocortisone—NR3C2—coronary artery disease	0.00138	0.186	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Lisinopril—coronary artery disease	0.0012	0.126	CbGdCrCtD
Fluocinolone Acetonide—Betamethasone—PLA2G1B—coronary artery disease	0.00118	0.16	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Ramipril—coronary artery disease	0.00116	0.122	CbGdCrCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C2—coronary artery disease	0.000967	0.131	CrCbGaD
Fluocinolone Acetonide—Prednisolone—NR3C2—coronary artery disease	0.000905	0.122	CrCbGaD
Fluocinolone Acetonide—Betamethasone—NR3C2—coronary artery disease	0.000886	0.12	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—PLA2G1B—coronary artery disease	0.000689	0.0931	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NR3C2—coronary artery disease	0.000516	0.0697	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NOS2—coronary artery disease	0.000308	0.0416	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Simvastatin—coronary artery disease	0.000292	0.000726	CcSEcCtD
Fluocinolone Acetonide—Headache—Rosuvastatin—coronary artery disease	0.000292	0.000726	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Timolol—coronary artery disease	0.000292	0.000725	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Lovastatin—coronary artery disease	0.000291	0.000724	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Ramipril—coronary artery disease	0.000291	0.000722	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000291	0.000722	CcSEcCtD
Fluocinolone Acetonide—Pain—Niacin—coronary artery disease	0.00029	0.000722	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Timolol—coronary artery disease	0.00029	0.000721	CcSEcCtD
Fluocinolone Acetonide—Erythema—Timolol—coronary artery disease	0.00029	0.000721	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000288	0.000716	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Furosemide—coronary artery disease	0.000287	0.000713	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fenofibrate—coronary artery disease	0.000286	0.000712	CcSEcCtD
Fluocinolone Acetonide—Pain—Pravastatin—coronary artery disease	0.000286	0.00071	CcSEcCtD
Fluocinolone Acetonide—Rash—Acetylsalicylic acid—coronary artery disease	0.000286	0.00071	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Ezetimibe—coronary artery disease	0.000286	0.00071	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000286	0.000709	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Timolol—coronary artery disease	0.000284	0.000706	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000283	0.000702	CcSEcCtD
Fluocinolone Acetonide—Oedema—Losartan—coronary artery disease	0.000282	0.000702	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Clopidogrel—coronary artery disease	0.000282	0.0007	CcSEcCtD
Fluocinolone Acetonide—Infection—Losartan—coronary artery disease	0.000281	0.000697	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.00028	0.000696	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Lovastatin—coronary artery disease	0.00028	0.000695	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Lisinopril—coronary artery disease	0.000279	0.000692	CcSEcCtD
Fluocinolone Acetonide—Nausea—Rosuvastatin—coronary artery disease	0.000277	0.000689	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Fenofibrate—coronary artery disease	0.000277	0.000688	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Losartan—coronary artery disease	0.000277	0.000688	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000275	0.000684	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Olmesartan—coronary artery disease	0.000275	0.000683	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ezetimibe—coronary artery disease	0.000274	0.000682	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000274	0.000682	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Timolol—coronary artery disease	0.000273	0.000679	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Lisinopril—coronary artery disease	0.000273	0.000679	CcSEcCtD
Fluocinolone Acetonide—Pain—Telmisartan—coronary artery disease	0.000273	0.000678	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Simvastatin—coronary artery disease	0.000272	0.000677	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Clopidogrel—coronary artery disease	0.000272	0.000677	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Lisinopril—coronary artery disease	0.000271	0.000673	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Lovastatin—coronary artery disease	0.000271	0.000672	CcSEcCtD
Fluocinolone Acetonide—Nausea—Acetylsalicylic acid—coronary artery disease	0.000269	0.000669	CcSEcCtD
Fluocinolone Acetonide—Erythema—Lisinopril—coronary artery disease	0.000269	0.000669	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Lisinopril—coronary artery disease	0.000269	0.000669	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Eplerenone—coronary artery disease	0.000269	0.000667	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Niacin—coronary artery disease	0.000268	0.000667	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Fenofibrate—coronary artery disease	0.000268	0.000665	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Ramipril—coronary artery disease	0.000267	0.000662	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ezetimibe—coronary artery disease	0.000265	0.000659	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Pravastatin—coronary artery disease	0.000264	0.000657	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Lisinopril—coronary artery disease	0.000264	0.000655	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Clopidogrel—coronary artery disease	0.000263	0.000654	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Simvastatin—coronary artery disease	0.000262	0.00065	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Lovastatin—coronary artery disease	0.000261	0.00065	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Timolol—coronary artery disease	0.000261	0.000648	CcSEcCtD
Fluocinolone Acetonide—Back pain—Lisinopril—coronary artery disease	0.00026	0.000647	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00026	0.000646	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Eplerenone—coronary artery disease	0.00026	0.000645	CcSEcCtD
Fluocinolone Acetonide—Cough—Ramipril—coronary artery disease	0.000259	0.000643	CcSEcCtD
Fluocinolone Acetonide—Pain—Perindopril—coronary artery disease	0.000258	0.00064	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Fenofibrate—coronary artery disease	0.000257	0.00064	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000257	0.000639	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Valsartan—coronary artery disease	0.000257	0.000639	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Trandolapril—coronary artery disease	0.000257	0.000638	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ezetimibe—coronary artery disease	0.000256	0.000637	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Enalapril—coronary artery disease	0.000256	0.000635	CcSEcCtD
Fluocinolone Acetonide—Rash—Fenofibrate—coronary artery disease	0.000255	0.000634	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fenofibrate—coronary artery disease	0.000255	0.000634	CcSEcCtD
Fluocinolone Acetonide—Headache—Fenofibrate—coronary artery disease	0.000254	0.00063	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Lisinopril—coronary artery disease	0.000254	0.00063	CcSEcCtD
Fluocinolone Acetonide—Cough—Timolol—coronary artery disease	0.000253	0.000629	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Clopidogrel—coronary artery disease	0.000253	0.000629	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Simvastatin—coronary artery disease	0.000253	0.000629	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000253	0.000628	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Ramipril—coronary artery disease	0.000253	0.000628	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Telmisartan—coronary artery disease	0.000252	0.000626	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Lovastatin—coronary artery disease	0.000251	0.000625	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Eplerenone—coronary artery disease	0.000251	0.000624	CcSEcCtD
Fluocinolone Acetonide—Rash—Clopidogrel—coronary artery disease	0.000251	0.000624	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Clopidogrel—coronary artery disease	0.000251	0.000623	CcSEcCtD
Fluocinolone Acetonide—Pain—Furosemide—coronary artery disease	0.00025	0.000622	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Niacin—coronary artery disease	0.00025	0.000622	CcSEcCtD
Fluocinolone Acetonide—Headache—Clopidogrel—coronary artery disease	0.000249	0.00062	CcSEcCtD
Fluocinolone Acetonide—Rash—Lovastatin—coronary artery disease	0.000249	0.000619	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Lovastatin—coronary artery disease	0.000249	0.000619	CcSEcCtD
Fluocinolone Acetonide—Headache—Lovastatin—coronary artery disease	0.000248	0.000615	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Valsartan—coronary artery disease	0.000247	0.000614	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Timolol—coronary artery disease	0.000247	0.000614	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ezetimibe—coronary artery disease	0.000247	0.000613	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Pravastatin—coronary artery disease	0.000246	0.000612	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Olmesartan—coronary artery disease	0.000246	0.000611	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Captopril—coronary artery disease	0.000245	0.000609	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Simvastatin—coronary artery disease	0.000245	0.000608	CcSEcCtD
Fluocinolone Acetonide—Rash—Ezetimibe—coronary artery disease	0.000245	0.000608	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ezetimibe—coronary artery disease	0.000244	0.000607	CcSEcCtD
Fluocinolone Acetonide—Headache—Ezetimibe—coronary artery disease	0.000243	0.000604	CcSEcCtD
Fluocinolone Acetonide—Oedema—Ramipril—coronary artery disease	0.000242	0.000602	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Lisinopril—coronary artery disease	0.000242	0.000601	CcSEcCtD
Fluocinolone Acetonide—Pain—Losartan—coronary artery disease	0.000242	0.0006	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Eplerenone—coronary artery disease	0.000241	0.0006	CcSEcCtD
Fluocinolone Acetonide—Nausea—Fenofibrate—coronary artery disease	0.000241	0.000598	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Niacin—coronary artery disease	0.00024	0.000597	CcSEcCtD
Fluocinolone Acetonide—Rash—Eplerenone—coronary artery disease	0.000239	0.000595	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Trandolapril—coronary artery disease	0.000239	0.000594	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Eplerenone—coronary artery disease	0.000239	0.000594	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Valsartan—coronary artery disease	0.000239	0.000594	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Enalapril—coronary artery disease	0.000238	0.000592	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Perindopril—coronary artery disease	0.000238	0.000591	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Olmesartan—coronary artery disease	0.000238	0.000591	CcSEcCtD
Fluocinolone Acetonide—Headache—Eplerenone—coronary artery disease	0.000238	0.000591	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Ramipril—coronary artery disease	0.000238	0.00059	CcSEcCtD
Fluocinolone Acetonide—Oedema—Timolol—coronary artery disease	0.000237	0.000588	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Pravastatin—coronary artery disease	0.000237	0.000588	CcSEcCtD
Fluocinolone Acetonide—Nausea—Clopidogrel—coronary artery disease	0.000236	0.000587	CcSEcCtD
Fluocinolone Acetonide—Infection—Timolol—coronary artery disease	0.000235	0.000584	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Simvastatin—coronary artery disease	0.000235	0.000584	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Telmisartan—coronary artery disease	0.000235	0.000584	CcSEcCtD
Fluocinolone Acetonide—Cough—Lisinopril—coronary artery disease	0.000235	0.000584	CcSEcCtD
Fluocinolone Acetonide—Nausea—Lovastatin—coronary artery disease	0.000235	0.000584	CcSEcCtD
Fluocinolone Acetonide—Rash—Simvastatin—coronary artery disease	0.000233	0.000579	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Simvastatin—coronary artery disease	0.000233	0.000579	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Niacin—coronary artery disease	0.000232	0.000577	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Timolol—coronary artery disease	0.000232	0.000577	CcSEcCtD
Fluocinolone Acetonide—Headache—Simvastatin—coronary artery disease	0.000232	0.000576	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Furosemide—coronary artery disease	0.000231	0.000575	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Valsartan—coronary artery disease	0.000231	0.000574	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ezetimibe—coronary artery disease	0.00023	0.000572	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Olmesartan—coronary artery disease	0.00023	0.000571	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Trandolapril—coronary artery disease	0.00023	0.000571	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Lisinopril—coronary artery disease	0.000229	0.000569	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Enalapril—coronary artery disease	0.000229	0.000568	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pravastatin—coronary artery disease	0.000229	0.000568	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Telmisartan—coronary artery disease	0.000226	0.000561	CcSEcCtD
Fluocinolone Acetonide—Nausea—Eplerenone—coronary artery disease	0.000225	0.00056	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Niacin—coronary artery disease	0.000225	0.000558	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Losartan—coronary artery disease	0.000223	0.000555	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Trandolapril—coronary artery disease	0.000222	0.000552	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Valsartan—coronary artery disease	0.000222	0.000552	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Enalapril—coronary artery disease	0.000221	0.00055	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Pravastatin—coronary artery disease	0.000221	0.000549	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Olmesartan—coronary artery disease	0.000221	0.000549	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000221	0.000548	CcSEcCtD
Fluocinolone Acetonide—Rash—Valsartan—coronary artery disease	0.00022	0.000547	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Valsartan—coronary artery disease	0.00022	0.000547	CcSEcCtD
Fluocinolone Acetonide—Nausea—Simvastatin—coronary artery disease	0.00022	0.000546	CcSEcCtD
Fluocinolone Acetonide—Oedema—Lisinopril—coronary artery disease	0.00022	0.000546	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Captopril—coronary artery disease	0.000219	0.000545	CcSEcCtD
Fluocinolone Acetonide—Rash—Olmesartan—coronary artery disease	0.000219	0.000545	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Olmesartan—coronary artery disease	0.000219	0.000544	CcSEcCtD
Fluocinolone Acetonide—Headache—Valsartan—coronary artery disease	0.000219	0.000544	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Telmisartan—coronary artery disease	0.000218	0.000542	CcSEcCtD
Fluocinolone Acetonide—Infection—Lisinopril—coronary artery disease	0.000218	0.000542	CcSEcCtD
Fluocinolone Acetonide—Headache—Olmesartan—coronary artery disease	0.000218	0.000541	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Niacin—coronary artery disease	0.000216	0.000536	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000216	0.000536	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Furosemide—coronary artery disease	0.000216	0.000536	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Trandolapril—coronary artery disease	0.000215	0.000533	CcSEcCtD
Fluocinolone Acetonide—Rash—Niacin—coronary artery disease	0.000214	0.000532	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Niacin—coronary artery disease	0.000214	0.000531	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Enalapril—coronary artery disease	0.000214	0.000531	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Perindopril—coronary artery disease	0.000213	0.000529	CcSEcCtD
Fluocinolone Acetonide—Headache—Niacin—coronary artery disease	0.000213	0.000529	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Pravastatin—coronary artery disease	0.000213	0.000528	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Captopril—coronary artery disease	0.000212	0.000527	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Telmisartan—coronary artery disease	0.000211	0.000524	CcSEcCtD
Fluocinolone Acetonide—Rash—Pravastatin—coronary artery disease	0.000211	0.000524	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Pravastatin—coronary artery disease	0.000211	0.000523	CcSEcCtD
Fluocinolone Acetonide—Headache—Pravastatin—coronary artery disease	0.000209	0.00052	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000209	0.00052	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Losartan—coronary artery disease	0.000208	0.000517	CcSEcCtD
Fluocinolone Acetonide—Nausea—Valsartan—coronary artery disease	0.000207	0.000515	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Furosemide—coronary artery disease	0.000207	0.000515	CcSEcCtD
Fluocinolone Acetonide—Nausea—Olmesartan—coronary artery disease	0.000206	0.000513	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Trandolapril—coronary artery disease	0.000206	0.000513	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Perindopril—coronary artery disease	0.000206	0.000512	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Enalapril—coronary artery disease	0.000206	0.000511	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Captopril—coronary artery disease	0.000205	0.00051	CcSEcCtD
Fluocinolone Acetonide—Rash—Trandolapril—coronary artery disease	0.000205	0.000509	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Trandolapril—coronary artery disease	0.000205	0.000508	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Timolol—coronary artery disease	0.000204	0.000508	CcSEcCtD
Fluocinolone Acetonide—Rash—Enalapril—coronary artery disease	0.000204	0.000507	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Enalapril—coronary artery disease	0.000204	0.000506	CcSEcCtD
Fluocinolone Acetonide—Headache—Trandolapril—coronary artery disease	0.000203	0.000505	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Telmisartan—coronary artery disease	0.000203	0.000504	CcSEcCtD
Fluocinolone Acetonide—Headache—Enalapril—coronary artery disease	0.000203	0.000503	CcSEcCtD
Fluocinolone Acetonide—Pain—Timolol—coronary artery disease	0.000202	0.000503	CcSEcCtD
Fluocinolone Acetonide—Nausea—Niacin—coronary artery disease	0.000202	0.000501	CcSEcCtD
Fluocinolone Acetonide—Rash—Telmisartan—coronary artery disease	0.000201	0.0005	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Telmisartan—coronary artery disease	0.000201	0.000499	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Furosemide—coronary artery disease	0.0002	0.000498	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.0002	0.000497	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Losartan—coronary artery disease	0.0002	0.000497	CcSEcCtD
Fluocinolone Acetonide—Headache—Telmisartan—coronary artery disease	0.0002	0.000496	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Perindopril—coronary artery disease	0.000199	0.000495	CcSEcCtD
Fluocinolone Acetonide—Nausea—Pravastatin—coronary artery disease	0.000199	0.000493	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Captopril—coronary artery disease	0.000197	0.00049	CcSEcCtD
Fluocinolone Acetonide—Rash—Captopril—coronary artery disease	0.000196	0.000486	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Captopril—coronary artery disease	0.000195	0.000485	CcSEcCtD
Fluocinolone Acetonide—Headache—Captopril—coronary artery disease	0.000194	0.000483	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Furosemide—coronary artery disease	0.000194	0.000481	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Losartan—coronary artery disease	0.000193	0.00048	CcSEcCtD
Fluocinolone Acetonide—Nausea—Trandolapril—coronary artery disease	0.000193	0.000479	CcSEcCtD
Fluocinolone Acetonide—Nausea—Enalapril—coronary artery disease	0.000192	0.000477	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Perindopril—coronary artery disease	0.000191	0.000476	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Ramipril—coronary artery disease	0.000191	0.000476	CcSEcCtD
Fluocinolone Acetonide—Rash—Perindopril—coronary artery disease	0.00019	0.000472	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Perindopril—coronary artery disease	0.00019	0.000471	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.00019	0.000471	CcSEcCtD
Fluocinolone Acetonide—Nausea—Telmisartan—coronary artery disease	0.000189	0.000471	CcSEcCtD
Fluocinolone Acetonide—Headache—Perindopril—coronary artery disease	0.000189	0.000469	CcSEcCtD
Fluocinolone Acetonide—Pain—Lisinopril—coronary artery disease	0.000188	0.000467	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Timolol—coronary artery disease	0.000187	0.000465	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Losartan—coronary artery disease	0.000187	0.000464	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Furosemide—coronary artery disease	0.000186	0.000462	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—coronary artery disease	0.000185	0.025	CrCbGaD
Fluocinolone Acetonide—Rash—Furosemide—coronary artery disease	0.000185	0.000459	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Furosemide—coronary artery disease	0.000184	0.000458	CcSEcCtD
Fluocinolone Acetonide—Nausea—Captopril—coronary artery disease	0.000184	0.000458	CcSEcCtD
Fluocinolone Acetonide—Headache—Furosemide—coronary artery disease	0.000183	0.000456	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Losartan—coronary artery disease	0.00018	0.000446	CcSEcCtD
Fluocinolone Acetonide—Nausea—Perindopril—coronary artery disease	0.000179	0.000444	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Ramipril—coronary artery disease	0.000178	0.000443	CcSEcCtD
Fluocinolone Acetonide—Rash—Losartan—coronary artery disease	0.000178	0.000442	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Losartan—coronary artery disease	0.000178	0.000442	CcSEcCtD
Fluocinolone Acetonide—Headache—Losartan—coronary artery disease	0.000177	0.00044	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Timolol—coronary artery disease	0.000174	0.000433	CcSEcCtD
Fluocinolone Acetonide—Nausea—Furosemide—coronary artery disease	0.000174	0.000432	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Lisinopril—coronary artery disease	0.000174	0.000431	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ramipril—coronary artery disease	0.000171	0.000426	CcSEcCtD
Fluocinolone Acetonide—Nausea—Losartan—coronary artery disease	0.000168	0.000417	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Timolol—coronary artery disease	0.000168	0.000416	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ramipril—coronary artery disease	0.000166	0.000412	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Timolol—coronary artery disease	0.000162	0.000403	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Lisinopril—coronary artery disease	0.000162	0.000402	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ramipril—coronary artery disease	0.00016	0.000398	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Timolol—coronary artery disease	0.000157	0.000389	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Lisinopril—coronary artery disease	0.000155	0.000386	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ramipril—coronary artery disease	0.000154	0.000383	CcSEcCtD
Fluocinolone Acetonide—Rash—Ramipril—coronary artery disease	0.000153	0.000379	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ramipril—coronary artery disease	0.000153	0.000379	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—coronary artery disease	0.000152	0.0205	CrCbGaD
Fluocinolone Acetonide—Headache—Ramipril—coronary artery disease	0.000152	0.000377	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Timolol—coronary artery disease	0.000151	0.000374	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Lisinopril—coronary artery disease	0.00015	0.000373	CcSEcCtD
Fluocinolone Acetonide—Rash—Timolol—coronary artery disease	0.000149	0.000371	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Timolol—coronary artery disease	0.000149	0.000371	CcSEcCtD
Fluocinolone Acetonide—Headache—Timolol—coronary artery disease	0.000148	0.000369	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Lisinopril—coronary artery disease	0.000145	0.000361	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ramipril—coronary artery disease	0.000144	0.000357	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2C19—coronary artery disease	0.000142	0.0192	CrCbGaD
Fluocinolone Acetonide—Nausea—Timolol—coronary artery disease	0.000141	0.000349	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Lisinopril—coronary artery disease	0.00014	0.000347	CcSEcCtD
Fluocinolone Acetonide—Rash—Lisinopril—coronary artery disease	0.000138	0.000344	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Lisinopril—coronary artery disease	0.000138	0.000344	CcSEcCtD
Fluocinolone Acetonide—Headache—Lisinopril—coronary artery disease	0.000138	0.000342	CcSEcCtD
Fluocinolone Acetonide—Nausea—Lisinopril—coronary artery disease	0.00013	0.000324	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—PTGS2—coronary artery disease	8.83e-05	0.0119	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA1—coronary artery disease	7.2e-05	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	7.19e-05	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPA—coronary artery disease	7.12e-05	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—coronary artery disease	7.05e-05	0.00028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PGF—coronary artery disease	7e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPBP—coronary artery disease	7e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	6.98e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDNRA—coronary artery disease	6.98e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB1—coronary artery disease	6.95e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK14—coronary artery disease	6.94e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—coronary artery disease	6.92e-05	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCB3—coronary artery disease	6.89e-05	0.000274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGA2B—coronary artery disease	6.89e-05	0.000274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DVL1—coronary artery disease	6.89e-05	0.000274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	6.86e-05	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA5—coronary artery disease	6.82e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2—coronary artery disease	6.73e-05	0.000268	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FN1—coronary artery disease	6.73e-05	0.000268	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	6.72e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—P4HB—coronary artery disease	6.69e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL4—coronary artery disease	6.68e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHR—coronary artery disease	6.68e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OPRD1—coronary artery disease	6.68e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—coronary artery disease	6.65e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.63e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—GATA4—coronary artery disease	6.63e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLA2G1B—coronary artery disease	6.57e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—BDKRB2—coronary artery disease	6.57e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL12—coronary artery disease	6.57e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	6.56e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.49e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PLCB1—coronary artery disease	6.42e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.42e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TLE4—coronary artery disease	6.4e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MEF2A—coronary artery disease	6.4e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR4A1—coronary artery disease	6.34e-05	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR7—coronary artery disease	6.29e-05	0.00025	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA2—coronary artery disease	6.24e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—VCAN—coronary artery disease	6.19e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AVPR1A—coronary artery disease	6.16e-05	0.000245	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDOA—coronary artery disease	6.14e-05	0.000244	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—coronary artery disease	5.98e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KNG1—coronary artery disease	5.97e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DCN—coronary artery disease	5.96e-05	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—UTS2—coronary artery disease	5.95e-05	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGTR1—coronary artery disease	5.94e-05	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—coronary artery disease	5.89e-05	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	5.83e-05	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NR4A1—coronary artery disease	5.82e-05	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL10—coronary artery disease	5.8e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDH2—coronary artery disease	5.8e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NPPA—coronary artery disease	5.77e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC9—coronary artery disease	5.76e-05	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB3—coronary artery disease	5.76e-05	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—P2RY12—coronary artery disease	5.76e-05	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CR1—coronary artery disease	5.71e-05	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASR—coronary artery disease	5.71e-05	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.66e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2C19—coronary artery disease	5.65e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3C2A—coronary artery disease	5.65e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HBA1—coronary artery disease	5.65e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LIPC—coronary artery disease	5.65e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB2—coronary artery disease	5.63e-05	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOC3—coronary artery disease	5.62e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—coronary artery disease	5.6e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CL1—coronary artery disease	5.6e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—P4HB—coronary artery disease	5.6e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNA12—coronary artery disease	5.6e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BDKRB1—coronary artery disease	5.6e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—coronary artery disease	5.59e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—coronary artery disease	5.59e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LDLR—coronary artery disease	5.58e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.58e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCE—coronary artery disease	5.56e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—coronary artery disease	5.52e-05	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC9A1—coronary artery disease	5.52e-05	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP3R1—coronary artery disease	5.49e-05	0.000218	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCLC—coronary artery disease	5.45e-05	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CETP—coronary artery disease	5.45e-05	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADM—coronary artery disease	5.44e-05	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDC1—coronary artery disease	5.39e-05	0.000215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.36e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—coronary artery disease	5.34e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CYBB—coronary artery disease	5.3e-05	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4B—coronary artery disease	5.3e-05	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MMP3—coronary artery disease	5.29e-05	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—coronary artery disease	5.22e-05	0.000208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—JAK2—coronary artery disease	5.19e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PSMB5—coronary artery disease	5.1e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PSMA6—coronary artery disease	5.1e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.09e-05	0.000202	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—coronary artery disease	5.03e-05	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL5—coronary artery disease	4.99e-05	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CTGF—coronary artery disease	4.98e-05	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT2—coronary artery disease	4.93e-05	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMGCR—coronary artery disease	4.93e-05	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CSF2—coronary artery disease	4.92e-05	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR3—coronary artery disease	4.85e-05	0.000193	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—coronary artery disease	4.83e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRK—coronary artery disease	4.79e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	4.77e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—coronary artery disease	4.76e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ATP2A2—coronary artery disease	4.73e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VWF—coronary artery disease	4.73e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SH2B3—coronary artery disease	4.73e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOC3—coronary artery disease	4.7e-05	0.000187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LDLR—coronary artery disease	4.67e-05	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PSMB5—coronary artery disease	4.64e-05	0.000184	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PSMA6—coronary artery disease	4.64e-05	0.000184	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP2CA—coronary artery disease	4.58e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL2—coronary artery disease	4.56e-05	0.000181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL3—coronary artery disease	4.56e-05	0.000181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCB1—coronary artery disease	4.54e-05	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CTGF—coronary artery disease	4.53e-05	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SDC1—coronary artery disease	4.51e-05	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2R—coronary artery disease	4.51e-05	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCD—coronary artery disease	4.5e-05	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.45e-05	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGB—coronary artery disease	4.41e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—coronary artery disease	4.4e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—C3—coronary artery disease	4.4e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCA1—coronary artery disease	4.4e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRB—coronary artery disease	4.37e-05	0.000174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—THBS1—coronary artery disease	4.3e-05	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—coronary artery disease	4.29e-05	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSMB5—coronary artery disease	4.26e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSMA6—coronary artery disease	4.26e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT1—coronary artery disease	4.26e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GGT1—coronary artery disease	4.26e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—coronary artery disease	4.18e-05	0.000166	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—coronary artery disease	4.14e-05	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—JUNB—coronary artery disease	4.14e-05	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPA1A—coronary artery disease	4.14e-05	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRA—coronary artery disease	4.12e-05	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB1—coronary artery disease	4.11e-05	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CYBA—coronary artery disease	4.11e-05	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DUSP6—coronary artery disease	4.09e-05	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLAT—coronary artery disease	4.02e-05	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BDKRB2—coronary artery disease	3.88e-05	0.000154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL12—coronary artery disease	3.88e-05	0.000154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2—coronary artery disease	3.86e-05	0.000154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—coronary artery disease	3.85e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6ST—coronary artery disease	3.85e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—coronary artery disease	3.83e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUNB—coronary artery disease	3.81e-05	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB1—coronary artery disease	3.79e-05	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARGC1A—coronary artery disease	3.79e-05	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—coronary artery disease	3.77e-05	0.00015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAT—coronary artery disease	3.72e-05	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR7—coronary artery disease	3.71e-05	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOB—coronary artery disease	3.61e-05	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGAV—coronary artery disease	3.54e-05	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—coronary artery disease	3.53e-05	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KNG1—coronary artery disease	3.53e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—coronary artery disease	3.52e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CREB1—coronary artery disease	3.52e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—coronary artery disease	3.52e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR1—coronary artery disease	3.51e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK1—coronary artery disease	3.47e-05	0.000138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—coronary artery disease	3.45e-05	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—coronary artery disease	3.44e-05	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6R—coronary artery disease	3.43e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL10—coronary artery disease	3.43e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLG—coronary artery disease	3.42e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—coronary artery disease	3.37e-05	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—coronary artery disease	3.34e-05	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB2—coronary artery disease	3.33e-05	0.000132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCE—coronary artery disease	3.29e-05	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD36—coronary artery disease	3.28e-05	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS1—coronary artery disease	3.28e-05	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—S100B—coronary artery disease	3.27e-05	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPP2CA—coronary artery disease	3.24e-05	0.000129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS3—coronary artery disease	3.24e-05	0.000129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KITLG—coronary artery disease	3.2e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFBR2—coronary artery disease	3.2e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT5A—coronary artery disease	3.13e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP3—coronary artery disease	3.13e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—coronary artery disease	3.11e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOB—coronary artery disease	3.02e-05	0.00012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—coronary artery disease	3.01e-05	0.00012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—JAK2—coronary artery disease	2.98e-05	0.000119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—coronary artery disease	2.97e-05	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—coronary artery disease	2.95e-05	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL5—coronary artery disease	2.95e-05	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPP2CA—coronary artery disease	2.95e-05	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CSF2—coronary artery disease	2.91e-05	0.000116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF1—coronary artery disease	2.91e-05	0.000116	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PRKCD—coronary artery disease	2.89e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—coronary artery disease	2.89e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—coronary artery disease	2.89e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MEF2C—coronary artery disease	2.86e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPS6KB1—coronary artery disease	2.86e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—coronary artery disease	2.86e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGB3—coronary artery disease	2.79e-05	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.74e-05	0.000109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—coronary artery disease	2.72e-05	0.000108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP2CA—coronary artery disease	2.71e-05	0.000108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCD—coronary artery disease	2.66e-05	0.000106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—coronary artery disease	2.6e-05	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—C3—coronary artery disease	2.6e-05	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK14—coronary artery disease	2.56e-05	0.000102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—coronary artery disease	2.52e-05	0.0001	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—coronary artery disease	2.51e-05	9.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—coronary artery disease	2.48e-05	9.88e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—coronary artery disease	2.48e-05	9.85e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—coronary artery disease	2.47e-05	9.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—coronary artery disease	2.46e-05	9.77e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—coronary artery disease	2.42e-05	9.62e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—coronary artery disease	2.42e-05	9.62e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—coronary artery disease	2.39e-05	9.51e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—coronary artery disease	2.37e-05	9.42e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK14—coronary artery disease	2.35e-05	9.36e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—coronary artery disease	2.31e-05	9.18e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—coronary artery disease	2.29e-05	9.12e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2—coronary artery disease	2.28e-05	9.07e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—coronary artery disease	2.28e-05	9.07e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6ST—coronary artery disease	2.27e-05	9.03e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—coronary artery disease	2.27e-05	9.01e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKBIA—coronary artery disease	2.25e-05	8.96e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—coronary artery disease	2.18e-05	8.68e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—coronary artery disease	2.17e-05	8.62e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3B—coronary artery disease	2.09e-05	8.33e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—coronary artery disease	2.08e-05	8.26e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREB1—coronary artery disease	2.08e-05	8.26e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—coronary artery disease	2.07e-05	8.21e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—coronary artery disease	2.03e-05	8.09e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6R—coronary artery disease	2.03e-05	8.06e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—coronary artery disease	2e-05	7.95e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK1—coronary artery disease	1.99e-05	7.91e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—coronary artery disease	1.98e-05	7.88e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—coronary artery disease	1.9e-05	7.55e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—coronary artery disease	1.84e-05	7.31e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—coronary artery disease	1.81e-05	7.21e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAK2—coronary artery disease	1.76e-05	7e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—coronary artery disease	1.73e-05	6.86e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—coronary artery disease	1.61e-05	6.39e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—coronary artery disease	1.54e-05	6.12e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—coronary artery disease	1.53e-05	6.08e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—coronary artery disease	1.5e-05	5.96e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—coronary artery disease	1.45e-05	5.78e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—coronary artery disease	1.41e-05	5.61e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—coronary artery disease	1.31e-05	5.19e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—coronary artery disease	1.22e-05	4.85e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—coronary artery disease	1.2e-05	4.77e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK1—coronary artery disease	1.17e-05	4.67e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—coronary artery disease	1.02e-05	4.05e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—coronary artery disease	9.96e-06	3.96e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—coronary artery disease	9.06e-06	3.6e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—coronary artery disease	9.03e-06	3.59e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—coronary artery disease	8.33e-06	3.31e-05	CbGpPWpGaD
